Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and Readmission

NCT: NCT07866872 · ENROLLING_BY_INVITATION

NCT IDNCT07866872
StatusENROLLING_BY_INVITATION
Start Date2026-06-17
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The investigators are examining how adding relative blood volume monitoring (RBVM) to the best clinical practice affects outcomes (length of stay and rehospitalization) among dialysis patients hospitalized for or with volume overload.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑